CN104127431B - 一种兽用环丙-林可霉素长效注射液及其制备方法 - Google Patents
一种兽用环丙-林可霉素长效注射液及其制备方法 Download PDFInfo
- Publication number
- CN104127431B CN104127431B CN201410364634.5A CN201410364634A CN104127431B CN 104127431 B CN104127431 B CN 104127431B CN 201410364634 A CN201410364634 A CN 201410364634A CN 104127431 B CN104127431 B CN 104127431B
- Authority
- CN
- China
- Prior art keywords
- injection
- lincomycin
- ciprofloxacin
- long
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960005287 lincomycin Drugs 0.000 title claims abstract description 43
- 238000002347 injection Methods 0.000 title claims abstract description 40
- 239000007924 injection Substances 0.000 title claims abstract description 40
- 241001465754 Metazoa Species 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims abstract description 78
- 229960003405 ciprofloxacin Drugs 0.000 claims abstract description 34
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 21
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 claims abstract description 20
- 229960001595 lincomycin hydrochloride Drugs 0.000 claims abstract description 19
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008215 water for injection Substances 0.000 claims abstract description 15
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 14
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 14
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 14
- 239000004310 lactic acid Substances 0.000 claims abstract description 9
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 9
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 7
- VVTDHOIRNPCGTH-UHFFFAOYSA-N Mycosporin 1 Natural products COC1=C(NC(CO)CO)CC(O)(CO)CC1=O VVTDHOIRNPCGTH-UHFFFAOYSA-N 0.000 claims abstract description 6
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 241001662103 Cryptocarya corrugata Species 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 10
- 229960001229 ciprofloxacin hydrochloride Drugs 0.000 abstract description 5
- 244000144977 poultry Species 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 244000144972 livestock Species 0.000 abstract description 2
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 238000010025 steaming Methods 0.000 abstract 1
- 229940090044 injection Drugs 0.000 description 33
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical class CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 19
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 18
- 210000002381 plasma Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229940020010 ciprofloxacin injection Drugs 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 208000018569 Respiratory Tract disease Diseases 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000010255 intramuscular injection Methods 0.000 description 3
- 239000007927 intramuscular injection Substances 0.000 description 3
- 239000000273 veterinary drug Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- FGDQGIKMWOAFIK-UHFFFAOYSA-N acetonitrile;phosphoric acid Chemical compound CC#N.OP(O)(O)=O FGDQGIKMWOAFIK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410364634.5A CN104127431B (zh) | 2014-07-29 | 2014-07-29 | 一种兽用环丙-林可霉素长效注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410364634.5A CN104127431B (zh) | 2014-07-29 | 2014-07-29 | 一种兽用环丙-林可霉素长效注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104127431A CN104127431A (zh) | 2014-11-05 |
CN104127431B true CN104127431B (zh) | 2016-06-08 |
Family
ID=51800455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410364634.5A Expired - Fee Related CN104127431B (zh) | 2014-07-29 | 2014-07-29 | 一种兽用环丙-林可霉素长效注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104127431B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109528639A (zh) * | 2018-12-24 | 2019-03-29 | 江西润泽药业有限公司 | 一种用于制备复方盐酸林可霉素注射液的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101416936B (zh) * | 2007-10-22 | 2012-03-21 | 普莱柯生物工程股份有限公司 | 一种长效复方磺胺间甲氧嘧啶混悬液的制备方法 |
CN103622987B (zh) * | 2013-12-03 | 2015-11-25 | 湖北武当动物药业有限责任公司 | 一种兽用长效复方盐酸林可霉素注射液及其制备方法 |
-
2014
- 2014-07-29 CN CN201410364634.5A patent/CN104127431B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104127431A (zh) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751103B (zh) | 一种长效硫酸头孢喹肟注射液及其制备方法 | |
AU2007252183A1 (en) | Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and process thereof | |
CN103222978B (zh) | 复方磺胺甲噁唑注射液及制备方法 | |
CN104546703B (zh) | 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法 | |
Zhao et al. | Integration of pharmacokinetic and pharmacodynamic indices of valnemulin in broiler chickens after a single intravenous and intramuscular administration | |
CN109806273A (zh) | 泰拉霉素和加米霉素的复合溶液剂及其制备方法与应用 | |
CN104095871A (zh) | 一种含盐酸林可霉素与硫酸大观霉素的兽用注射液 | |
CN104127431B (zh) | 一种兽用环丙-林可霉素长效注射液及其制备方法 | |
CN105582019A (zh) | 一种替米考星固体分散剂及其制备方法 | |
CN105919933A (zh) | 泰地罗新注射液及其制备方法 | |
CN101982173B (zh) | 适用于畜禽的甲磺酸达氟沙星-阿莫西林混悬注射液及其制备与应用 | |
CN104161761B (zh) | 一种复方土霉素注射液及其制备方法 | |
CN105125484A (zh) | 一种无痛化的多西环素注射液及其制备方法 | |
CN105232450A (zh) | 含利福昔明的乳房注入用原位凝胶及其制备方法 | |
CN106362139B (zh) | 一种长效土霉素注射液及其制备方法 | |
CN103211818B (zh) | 一种治疗或预防家畜细菌性和支原体疾病的药物组合物及其用途 | |
CN104586777A (zh) | 盐酸头孢噻呋粉针剂及其制备方法与应用 | |
CN104906039B (zh) | 一种替米考星注射用混悬剂及其制备方法 | |
CN101574355B (zh) | 一种兽用复方抗菌注射液及其制备方法 | |
CN106943349A (zh) | 一种泰地罗新混悬注射液及其制备方法 | |
CN103271921B (zh) | 一种妥曲珠利与地克珠利的复方溶液的制备方法及其应用 | |
CN102552160A (zh) | 兽用甲磺酸达氟沙星缓释微球制剂及其制备方法与应用 | |
CN101824061B (zh) | 一种来自中药黄芩的黄芩苷离子对药物和制备方法及其用途 | |
CN104288152A (zh) | 一种兽用复方硫酸小檗碱注射剂及其制备方法 | |
CN103285013B (zh) | 一种防治牛猪肺炎疾病的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Jinni Inventor after: Wu Haigang Inventor after: Ye Zhaowei Inventor after: Liu Jia Inventor after: Li Yingxiao Inventor after: Zhao Yu Inventor before: Liu Jinni Inventor before: Wu Haigang Inventor before: Liu Jicheng Inventor before: Chen Peirong Inventor before: Liu Jia Inventor before: Zhao Yunhuan Inventor before: Li Yingxiao Inventor before: Xiao Shiwen |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160316 Address after: 464000 Xinyang agriculture and Forestry College, 49 new twenty-four Avenue, Yangshan New District, Henan, Xinyang Applicant after: Xinyang College of Agriculture and Forestry Address before: 464000 Department of animal science, Xinyang agriculture and Forestry College, sheep mountain new area, Henan, Xinyang Applicant before: Liu Jinni |
|
CB03 | Change of inventor or designer information |
Inventor after: Liu Jinni Inventor after: Yi Benchi Inventor after: Wu Haigang Inventor after: Ye Zhaowei Inventor after: Liu Jia Inventor after: Li Yingxiao Inventor after: Zhao Yu Inventor after: Jiao Fengchao Inventor after: Chen Min Inventor after: Zhao Yunhuan Inventor before: Liu Jinni Inventor before: Wu Haigang Inventor before: Ye Zhaowei Inventor before: Liu Jia Inventor before: Li Yingxiao Inventor before: Zhao Yu |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160608 Termination date: 20170729 |
|
CF01 | Termination of patent right due to non-payment of annual fee |